Scientists, UC San Francisco develop COVID-19 antiviral nasal spray, inhaler

Scientists and UC San Francisco announced an inhalable protection against COVID-19 with the goal of being produced into an affordable, over-the-counter antiviral medication in the coming months. UCSF is working to start human trials on what they have called “AeroNabs.” Get the full story in the video above.